Current Issue


Macular edema, cardiovascular disease associated in type 2 diabetes

Patients with diabetic macular edema or proliferative diabetic retinopathy should be followed more actively to prevent cardiovascular disease, study authors said.

Treatment deintensification uncommon in type 2 diabetes

Less than a quarter of patients with an HbA1c below 6.0% had a drug discontinued or a dosage decreased, even after the American Diabetes Association issued a practice advisory about the risk of mortality associated with intensive glucose control.

Screening tool identifies high-risk drivers with type 1 diabetes and website helps to avoid future accidents

Significant independent predictors of risk for driving mishaps included annual driving distance and presence of peripheral neuropathy. Researchers developed an 11-item questionnaire to further refine risk prediction.

MKSAP quiz: Second-line therapy

This month's quiz asks readers to evaluate a 56-year-old woman with type 2 diabetes who is unhappy with her recent HbA1c value and has been working toward weight reduction without success.

Spotlight on cognitive effects of diabetes

Two recent studies looked at the effects of diabetes on the brain, one focusing on mild cognitive impairment and the other on brain imaging findings.

Review: Sulfonylureas are associated with overall mortality and CV events vs other antihyperglycemics

A review looked at randomized trials that compared mortality rates among patients taking sulfonylureas versus several other classes of hypoglycemic drugs.

Review: Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF

The included studies focused on metformin use in patients with chronic kidney disease (CKD), congestive heart failure (CHF), chronic liver disease (CLD), or older age.

Study suggests less frequent retinopathy screening in low-risk patients with type 1 diabetes

Researchers modeled the effects of individualizing screening based on current retinal status and mean glycated hemoglobin level, finding that the overall number of exams could be reduced.

Physician editor: David V. O'Dell, MD, FACP